Login / Signup

Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.

Carmen ScheibenbogenFranziska SotznyJelka HartwigSandra BauerHelma FreitagKirsten WittkeWolfram DöhnerNadja JauertMadlen LoebelPatricia Grabowski
Published in: Journal of clinical medicine (2021)
Our data indicate that self-administered s.c. IgG treatment is feasible and led to clinical improvement in a subset of ME/CFS patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • randomized controlled trial
  • clinical trial
  • prognostic factors
  • patient reported outcomes
  • data analysis
  • study protocol